Exane Derivatives’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,240
Closed -$45.2K 713
2020
Q1
$45.2K Buy
+3,240
New +$45.2K 0.01% 340